A stumble on a curb. A missed step on the stairs. For millions of older Americans, an ordinary fall can end in a broken hip or a compressed vertebra, not because the fall was severe, but because their bones had been quietly losing density for years. The condition responsible, osteopenia, affects an estimated 43% of U.S. adults aged 50 and older, according to federal survey data. It produces no pain and no outward signs, yet it sits on a continuum that leads toward osteoporosis and the fractures that can permanently alter a person’s ability to live independently.
As of May 2026, with the oldest baby boomers now approaching their 80s, the scope of the problem and its downstream costs are becoming harder for the healthcare system to absorb.
How common osteopenia really is
The most reliable national estimate comes from the National Health and Nutrition Examination Survey (NHANES) conducted in 2017 and 2018. Researchers used dual-energy X-ray absorptiometry (DXA) scans at the femur neck and lumbar spine on a nationally representative sample. Among adults 50 and older, the age-adjusted prevalence of low bone mass was 43.1%. Osteoporosis, the more advanced stage, affected 12.6%. Women carried a disproportionate share of both figures.
Those results were not a surprise. An earlier peer-reviewed analysis of the NHANES III survey, conducted from 1988 to 1994, had already documented high rates of low femoral bone density among older adults using DXA measurements at the femur. The fact that roughly 40% prevalence has held across two survey periods separated by more than two decades suggests the problem is deeply rooted in the biology of aging, not simply an artifact of better screening.
What the T-score means and why it matters
Osteopenia is defined by a scoring system developed by a World Health Organization Study Group in 1994 and still used worldwide. A DXA scan produces a T-score that compares an individual’s bone mineral density to the average peak density of a healthy young adult. A T-score between negative 1.0 and negative 2.5 falls into the osteopenia range, as shown in the WHO classification table. A score below negative 2.5 indicates osteoporosis.
The numbers are not just labels. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, fracture risk increases roughly 1.5 to 2 times for every one-point drop in T-score. That means someone at negative 2.0 faces about double the fracture risk of someone at negative 1.0, even though both are technically still in the osteopenia category. The U.S. Surgeon General’s report on bone health documented that low bone mass is directly linked to increased fracture risk over time, with consequences that range from chronic pain to permanent loss of mobility.
Who should be screened
The U.S. Preventive Services Task Force (USPSTF) recommends DXA screening for all women aged 65 and older, and for younger postmenopausal women whose clinical risk profile warrants it. For men, there is no universal screening recommendation, though clinicians often order scans for those with risk factors such as long-term corticosteroid use, low body weight, or a history of fragility fractures. The FRAX tool, developed by the University of Sheffield and endorsed by the WHO, combines T-score data with clinical risk factors like age, smoking status, and family history to estimate a patient’s 10-year probability of a major osteoporotic fracture. Many clinicians use that probability to guide decisions about whether someone with osteopenia needs closer monitoring or pharmacologic treatment.
What remains uncertain
Despite the strong prevalence data, several gaps persist. The NHANES figures cover adults 50 and older. Reliable nationwide data on osteopenia rates among people in their 30s and 40s is largely absent, making it difficult to know how early population-level thinning begins or which younger groups might benefit from earlier attention.
How fast osteopenia progresses to osteoporosis is also poorly quantified. No large-scale longitudinal study has directly measured conversion rates over a decade in a general population. Clinicians rely on smaller cohort analyses that vary in their populations, measurement sites, and follow-up periods, producing a range of estimates rather than a single reliable timeline.
The question of what slows or reverses bone loss at the osteopenia stage lacks the kind of definitive evidence that exists for osteoporosis treatment. Weight-bearing and resistance exercise, adequate calcium intake, and sufficient vitamin D are widely recommended, and smaller trials, including research on high-intensity resistance training, have shown measurable bone density improvements in postmenopausal women with low bone mass. But no large randomized controlled trial has established that a specific regimen reduces osteopenia progression by a precise amount in a broad adult population. For pharmacologic options like bisphosphonates, the strongest trial evidence supports their use in osteoporosis; prescribing them for osteopenia alone remains a clinical judgment call, typically reserved for patients whose FRAX scores indicate elevated fracture risk.
Racial and ethnic disparities add further complexity. NHANES data includes some demographic breakdowns, but direct research examining how risk factors and bone loss trajectories differ across diverse populations is limited. Secondary reports on health disparities often draw from the same survey data rather than independent measurement.
What people with osteopenia can actually do
For the tens of millions of Americans who fall into the osteopenia range, the diagnosis is not a guarantee of fractures. It is a signal that bone health deserves active attention. The evidence, while imperfect, consistently points toward a few practical steps:
- Weight-bearing and resistance exercise: Walking, jogging, stair climbing, and strength training place mechanical stress on bones that stimulates remodeling. The American College of Sports Medicine has long recommended these activities for bone health in older adults.
- Calcium and vitamin D: The National Institutes of Health recommends 1,000 to 1,200 milligrams of calcium daily for adults over 50, primarily from food sources, along with 600 to 800 IU of vitamin D. Blood levels of vitamin D can be checked with a simple test.
- Fall prevention: Because fractures require both weakened bone and a triggering event, reducing fall risk through balance exercises, home safety modifications, and vision correction is as important as strengthening the skeleton itself.
- Follow-up screening: A single DXA scan is a snapshot. Repeat scans, typically every two years, help track whether bone density is stable, improving, or declining, and inform decisions about whether treatment should escalate.
None of these steps require a prescription, and none carry significant risk. For higher-risk patients, a conversation with a clinician about FRAX scores and whether medication is warranted can clarify the next move.
Why the numbers keep growing
The 43% prevalence figure from NHANES reflects a biological reality: bone density peaks in early adulthood and declines with age in virtually everyone. As the U.S. population ages, the absolute number of people living with osteopenia will continue to rise even if the age-adjusted rate stays flat. Each year, a portion of those individuals will cross the threshold into osteoporosis, and a subset will experience fractures that carry serious consequences. Hip fractures alone are associated with a one-year mortality rate of roughly 20% in older adults, according to data compiled in orthopedic and geriatric literature.
The challenge is not that osteopenia is a new problem. It is that the population most vulnerable to it is larger than ever, and the window for intervention, before a fracture occurs, is still underused. Screening rates remain below recommended levels, and many people learn about their bone density only after a break sends them to the emergency room. Closing that gap is less a matter of new science than of applying what is already known to the people who need it most.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
